- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04976946
Protocol for CAMUS Delphi Study
Protocol for CAMUS Delphi Study: A Consensus on Reporting of Complications After Urological Surgeries
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
The CAMUS Delphi Study: A Consensus on Reporting of Complications After Urological Surgeries is a multi-staged, international Delphi study that aims to establish criteria for standardised complication reporting in Urology. The initial survey consists of a 12-part questionnaire that will aim to reach consensus on a wide range of contentious issues in Urological surgery using the frameworks of both the established Clavien-Dindo Classification (CDC) and the new CAMUS Classification.
To ensure comprehensive and comparable complication reporting across centres worldwide, a conclusive uniform language for reporting complications must be created and subsequently integrated. Accurate reporting will allow for more precise allocation of resources, improve unit efficiency, and reduce healthcare burden, while providing clinicians with a better understanding of intra- and post-operative morbidity. If a comprehensive, homogenous reporting construct is integrated worldwide, the potential to build and develop a universal database with complications from all centres around the world will surely provide invaluable data to create new guidelines and recommendations, ultimately improving patient counselling and surgical quality of care.
Studietype
Registrering (Forventet)
Kontakter og plasseringer
Studiesteder
-
-
-
Melbourne, Australia
- The Royal Melbourne Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Local and international consultant Urologists, accredited Urology trainees, consultant Anaesthetists and consultant ICU specialists will be invited to complete the survey. Critical care physicians who are primarily Urological anaesthetists or have experience in complication reporting will be targeted.
Exclusion Criteria:
- All other specialists that do not meet the inclusion criteria.
- Under 18 years of age.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
Urologists
Local and international consultant Urologists and accredited Urology trainees.
|
Multi-staged, international Delphi study that aims to establish criteria for standardised complication reporting in Urology.
|
|
Anaesthetists
Local and international consultant anaesthetists.
Critical care physicians who are primarily Urological anaesthetists or have experience in complication reporting will be targeted.
|
Multi-staged, international Delphi study that aims to establish criteria for standardised complication reporting in Urology.
|
|
ICU specialists
Local and international consultant ICU specialists.
Critical care physicians who are primarily Urological focused or have experience in complication reporting will be targeted.
|
Multi-staged, international Delphi study that aims to establish criteria for standardised complication reporting in Urology.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Standardised complication reporting in Urology
Tidsramme: 6 months
|
Establish criteria for standardised complication reporting in Urology
|
6 months
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Marc A Furrer, MD, Melbourne Health
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- 2020.046
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .